NasdaqCM - Nasdaq Real Time Price USD

IMAC Holdings, Inc. (BACK)

Compare
1.2057
-0.0543
(-4.31%)
As of 2:28:20 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
15.7500
--
--
14,385.8280
12,835.1980
Cost of Revenue
1,723.2100
--
1,508.4080
1,628.2060
1,623.9990
Gross Profit
15,359.6560
--
14,677.2740
12,757.6220
11,211.1990
Operating Expense
2,564.0020
2,941.6240
7,323.9090
22,706.5170
17,683.7130
Operating Income
-2,620.2540
-2,941.6240
-7,323.9090
-9,948.8950
-6,472.5140
Net Non Operating Interest Income Expense
-127.1810
-97.8100
6.6870
-501.2180
-556.9940
Other Income Expense
-4,061.3020
-3,435.9240
-4,513.7630
-92.1350
1,487.0700
Pretax Income
-5,881.6030
-6,475.3580
-11,830.9850
-10,542.2470
-5,542.4380
Net Income Common Stockholders
-6,834.7290
-9,418.5850
-18,312.8060
-10,542.2470
-5,542.4380
Diluted NI Available to Com Stockholders
-6,834.7290
-9,418.5850
-18,312.8060
-10,542.2470
-5,542.4380
Basic EPS
-6.00
-8.47
-19.43
-14.10
-15.00
Diluted EPS
-6.00
-8.47
-19.43
-14.10
-15.00
Basic Average Shares
1,144.0200
1,111.8440
942.4630
751.7230
368.3380
Diluted Average Shares
1,144.0200
1,111.8440
942.4630
751.7230
368.3380
Total Operating Income as Reported
-5,752.3820
-6,375.5080
-11,837.0980
-10,098.3580
-6,536.2930
Total Expenses
2,636.0040
2,941.6240
7,323.9090
24,334.7230
19,307.7120
Net Income from Continuing & Discontinued Operation
-6,107.2480
-9,418.5850
-18,312.8060
-10,542.2470
-5,542.4380
Normalized Income
-2,749.4750
-3,041.4740
-7,317.7980
-10,392.7830
-7,029.5020
Interest Income
28.1480
27.1560
9.8390
2.8850
6.0730
Interest Expense
155.3290
124.9660
3.1520
504.1030
563.0670
Net Interest Income
-127.1810
-97.8100
6.6870
-501.2180
-556.9940
EBIT
-5,726.2740
-6,350.3920
-11,827.8330
-10,038.1440
-4,979.3710
EBITDA
-5,597.5040
-5,946.7990
-10,201.2190
-8,388.9570
-3,256.9060
Reconciled Cost of Revenue
1,723.2100
--
1,508.4080
1,628.2060
1,623.9990
Reconciled Depreciation
128.7700
403.5930
1,626.6140
1,649.1870
1,722.4650
Net Income from Continuing Operation Net Minority Interest
-5,881.6030
-6,475.3580
-11,830.9870
-10,542.2470
-5,542.4380
Total Unusual Items Excluding Goodwill
-3,132.1280
-3,433.8840
-4,513.1890
-149.4640
1,487.0640
Total Unusual Items
-3,132.1280
-3,433.8840
-4,513.1890
-149.4640
1,487.0640
Normalized EBITDA
-2,465.3760
-2,512.9150
-5,688.0300
-8,239.4930
-4,743.9700
12/31/2020 - 2/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TOI The Oncology Institute, Inc.
0.3083
+2.19%
 
JYNT The Joint Corp.
10.32
+2.89%
 
FME.DE Fresenius Medical Care AG
43.43
-1.47%
 
HLYK HealthLynked Corp.
0.0185
+15.62%
 
KDLY Kindly MD, Inc.
1.3837
-3.20%
 
NVOS Novo Integrated Sciences, Inc.
0.0989
+11.53%
 
OPCH Option Care Health, Inc.
27.57
+14.92%
 
AGL agilon health, inc.
2.8550
+17.52%
 
NIVF NewGenIvf Group Limited
0.3233
-12.62%
 
SYRA Syra Health Corp.
0.4950
-15.49%